Medical Oncologist
CION Cancer Clinics
GATA2 mutation: which cancers, and how high the risk is | CION Cancer Clinics
A GATA2 fault mainly raises the risk of bone marrow cancers, especially myelodysplastic syndrome and acute myeloid leukaemia. The risk is high and often shows in the teenage years or early adulthood, but it is not certain for any one person. This page explains which cancers are involved, how marrow disease usually develops, and which findings on a check-up should raise concern. At CION Cancer Clinics, our oncologists explain what a gene result means for you and your family, and plan the checks that follow.
BP
Medically reviewed by Dr. Basudev PokhrelConsultant Haematologist · last reviewed September 2026, next review due September 2027
17+specialists on panel
15,000+patients treated
35+centres across Telangana & AP
4.8★ / 800+Google rating
On this page
- Which cancers does a GATA2 fault raise the risk of?
- What are the cancers linked with GATA2?
- How does marrow disease usually develop in GATA2 deficiency?
- What do the words on a marrow report mean?
- Which findings raise concern, and which are reassuring?
- What this page cannot tell you
- Four things families believe about GATA2 and cancer
- Common questions about GATA2 cancer risk
The short answer
Which cancers does a GATA2 fault raise the risk of?
Mainly cancers of the bone marrow. A GATA2 fault present from birth sharply raises the chance of myelodysplastic syndrome, a condition where the marrow makes faulty blood cells, and of acute myeloid leukaemia. It also raises the risk of a few cancers linked to viruses, such as HPV. It does not raise the risk of the common adult cancers in the way BRCA faults do.
How high is the risk?
Among inherited blood cancer genes, GATA2 carries one of the highest risks. Most published studies find that a large share of people with GATA2 deficiency, the inherited condition, develop marrow disease at some point. It is still not certain for any one person. Some relatives with the same fault reach later life with only mild problems.
When does it tend to happen?
Earlier than most cancers. Marrow disease often appears in the teenage years or early adulthood, though it can come in childhood or much later. Among teenagers with myelodysplastic syndrome and a missing chromosome seven, GATA2 is one of the most common inherited causes found. That is why checks start young.
A raised risk is a reason to be watched. It is not a diagnosis of cancer.The cancers involved
What are the cancers linked with GATA2?
The first two account for most of the risk. The others are less common, but they shape the check-up plan.
Myelodysplastic syndrome
The most common cancer in GATA2 deficiency. The marrow is often emptier than normal and the cells look abnormal. It can stay stable for a while or move on to leukaemia.
Often shows up as
- Falling blood counts over months
- A lost chromosome seven or an extra chromosome eight
- Tiredness, infections or bruising
Acute myeloid leukaemia
A fast-growing cancer of the marrow. In GATA2 deficiency it usually develops out of myelodysplastic syndrome rather than out of the blue, which is why the earlier stage is watched so closely.
Chronic myelomonocytic leukaemia
A slower marrow cancer that some adults with GATA2 develop. It is less common than the first two and is found through the same blood and marrow checks.
Cancers linked to viruses
Because the immune system is weak, HPV can cause cancers of the cervix, vulva, anus, and mouth or throat. Rarer tumours linked to other viruses, and some skin cancers, have also been reported.
Not sure whether this applies to you?
Ask an oncologistStep by step
How does marrow disease usually develop in GATA2 deficiency?
-
Immune cells run low first
Monocytes, B cells and natural killer cells fall, often for years. Many people feel well and have no reason to be tested.
-
The marrow empties out
The stem cells that make blood slowly wear down. A marrow sample may look emptier than expected for the person's age.
-
A chromosome change appears
Losing a chromosome seven or gaining a chromosome eight in the marrow cells is a common turning point. It means a group of cells has started to behave differently.
-
Myelodysplastic syndrome is diagnosed
Blood counts fall further and the cells look abnormal under the microscope. This is usually when a transplant is discussed seriously.
-
Leukaemia can follow
Without treatment, some people move on to acute myeloid leukaemia. Regular checks aim to act before this stage, when a transplant is more likely to go well.
On your report
What do the words on a marrow report mean?
- Myelodysplastic syndrome, or MDS
- A marrow condition in which blood cells are made faultily. It is counted as a type of blood cancer.
- Acute myeloid leukaemia, or AML
- A fast-growing cancer of the marrow cells that normally become white cells.
- Hypocellular marrow
- A marrow with fewer cells than expected. It is common in GATA2 deficiency, even before any cancer.
- Monosomy seven
- One copy of chromosome seven is missing from the marrow cells. It is a warning sign that disease is moving on.
- Trisomy eight
- An extra copy of chromosome eight in the marrow cells. It is another change doctors watch for.
- Penetrance
- How often a fault leads to illness across everyone who carries it. For GATA2 it is high, but never all.
Leave a number, we will call you
One field. No form to fill in, and no charge for the call.
Side by side
Which findings raise concern, and which are reassuring?
Raises concern
More reassuring
Blood counts falling between checks
Counts low but steady over time
A new chromosome change in the marrow
Marrow chromosomes normal on repeat tests
Serious or repeated infections
Few infections, well controlled
New faults in other genes in the marrow
No new marrow faults found
Abnormal-looking cells under the microscope
An empty marrow with normal-looking cells
Being straight with you
What this page cannot tell you
It cannot give you your own risk. The chance of marrow disease depends partly on the type of fault, and partly on factors nobody yet understands. What your specific variant means is a question for the counsellor or haematologist who ordered the test.
The evidence is still thin
GATA2 deficiency was only described in the last couple of decades. Studies so far are small, and most come from Europe and the United States. Very little is known about how the condition behaves in Indian families, so published figures should be read as a rough guide, not a forecast.
Who this does not apply to
Most people with a low blood count do not have GATA2 deficiency, and most leukaemia is not inherited. If a GATA2 change was found only inside leukaemia cells, and not in the rest of the body, it tells you about the cancer rather than the family. That question is covered under tumour testing and targeted therapy. A variant of uncertain significance, a change the laboratory cannot yet classify, should not be read as raised risk either.
Commonly believed
Four things families believe about GATA2 and cancer
"A GATA2 fault means leukaemia is certain."
The risk is high but not certain. Some people with the fault reach middle age or beyond without marrow cancer, and checks aim to catch changes before leukaemia.
"If I feel well, my marrow must be fine."
Early marrow changes often cause no symptoms. They are found on blood counts and marrow tests, which is why checks continue when you feel well.
"GATA2 raises the risk of every cancer."
The risk is concentrated in the marrow, with a smaller rise in cancers caused by viruses such as HPV. It is not a general cancer gene like BRCA1 or BRCA2.
"My parent had the fault and was fine, so I will be too."
The same fault can behave very differently in two relatives. A mild course in a parent does not predict a mild course in a child.
Questions we are asked
Common questions about GATA2 cancer risk
Is myelodysplastic syndrome the same as leukaemia?
Not quite. It is a marrow condition in which blood cells are made faultily, and it is counted as a blood cancer. In GATA2 deficiency it can move on to acute myeloid leukaemia, which is why it is treated seriously even when it seems stable.
At what age does the risk start?
It can start in childhood, and it is highest from the teenage years through early adulthood. It does not disappear with age. Adults who have been well so far still need regular checks.
Can anything lower the risk of marrow cancer?
No medicine is known to prevent it. What changes the outcome is timing. Regular checks let the team plan a stem cell transplant before marrow disease becomes advanced, and a transplant replaces the faulty marrow.
Does GATA2 raise the risk of breast or bowel cancer?
Not in any clear way. The risk sits mainly in the marrow, with a smaller rise in cancers linked to HPV and other viruses. Routine screening for other cancers follows the usual advice for your age.
Why does HPV matter so much?
With few natural killer cells and B cells, the body struggles to clear HPV. Warts spread and linger, and long-lasting infection can lead to cancers of the cervix, vulva, anus or throat. Vaccination and regular checks lower that risk.
Is the risk the same for every GATA2 fault?
Not exactly. Some types of fault seem linked to earlier or more severe disease, but studies are small and the pattern is not firm enough to predict one person's course. Your haematologist will explain what is known about your fault.
If I develop leukaemia, is treatment different?
Yes, in some ways. A stem cell transplant is usually part of the plan, because the underlying marrow problem remains after chemotherapy. Any family donor must first test negative for the GATA2 fault.
Who can explain my own risk?
A haematologist working with a genetic counsellor. Bring your report, past blood counts and any marrow results. Call the CION helpline if you are unsure where to start, and we will help you reach the right clinic.
Your Specialists
Meet CION's oncologists. Bring your family history or genetic report to them.
Our medical oncologists see people with a strong family history of cancer, arrange genetic counselling and testing where it fits, and plan the checks that follow.
Medical Oncologist
Dr. C. Raghavendra Reddy
MBBS(Gold Medal), DNB(General Medicine), DM(Medical Oncology)(Gold Medal)
Medical Oncologist
Dr. Bharati Devi Gorantla
MBBS, MD(General Medicine), DM(Medical Oncology)(Adyar,Chennai), ECMO, MRCP SCE(UK)
Medical Oncologist
Dr. Owais Mohammed
MBBS, MD (General Medicine), DrNB (Medical Oncology), ECMO, MRCP SCE (Medical Oncology) (UK)
Medical Oncologist
Medical Oncologist
Hematologist
Want a specific doctor for your case? Mention them when booking.
Book Free ConsultationBook an appointment with our specialist
Share your name and number — we'll call you back within 30 minutes to schedule your consultation.
Sources
- MedlinePlus Genetics — GATA2 deficiency
- Blood (American Society of Hematology) — The spectrum of GATA2 deficiency syndrome
- National Cancer Institute — Human Papillomavirus (HPV) Vaccine
- Cancer Research UK — Inherited cancer genes and increased cancer risk
This page is general information, not a prescription. Do not change or stop any treatment based on what you read here. If anything is worrying you, contact your own treating team — or call our helpline and we will help you reach the right specialist.
Keep reading
Related pages
The GATA2 gene: what it does and why it mattersWhy one faulty copy strains the marrowSurveillance for GATA2 carriersThe checks that catch marrow changes earlyGATA2 deficiency: infections before cancerThe infections that often come firstGATA2 positive: what happens nextThe practical steps after a positive result
Talk to us
Want your own risk explained?
Bring your GATA2 report, past blood counts and any marrow results. We can arrange a review with a haematologist and genetic counsellor who will explain what they mean for you. One helpline serves every CION centre.